Eli Lilly & Co. v. Cameron

Eli Lilly & Co. v. Cameron, Int. 104,104, Paper 18 (October 31, 2001) [Interferences - procedure - request for adverse judgment]Ptab Interferences

Full text

_______________
_______________
_______________
_______________
The opinion in support of the decision being
entered today is not binding precedent of the Board.
Paper 18
Filed by: Trial Section Motions Panel
Box Interference 	Filed: October 31, 2001
Washington, D.C. 20231
Tel: 703-308-9797
Fax: 703-305-0942
UNITED STATES PATENT AND TRADEMARK OFFICE
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
ELI LILLY AND COMPANY,
Junior Party,
(U.S. Patent 5,688,796),
v.
KIMBERLY O. CAMERON, PAUL DA SILVA-JARDINE, ERIC R. LARSON,
JAMES R. HAUSKE and ROBERT L. ROSATI
Senior Party
(Application 08/628,605).
Patent Interference No. 104,104 (MPT)
Before: McKELVEY, Senior Administrative Patent Judge, and LEE and TIERNEY,
Administrative Patent Judges.
TIERNEY, Administrative Patent Judge.
JUDGMENT
(Pursuant to 37 CFR § 1.662(a))
Lilly abandons the contest and has requested entry of adverse judgment. (Eli Lilly
Abandonment of Contest, Paper No. 17). Lilly attempts, however, to characterize and limit the
affect of their request for adverse judgment. Specifically, Lilly states that:
The compounds and methods encompassed by the count are not
commercially significant to Lilly. Therefore, Lilly abandons the contest
pursuant to 37 C.F.R. § 1.662(a).
Interference No. 104,104
Page No. 2
This abandonment of the contest is not an admission that Lilly agrees
with the proposed count, the designation of the claims or even the
patentability of Cameron's claims to Cameron. Further, Lilly reserves the
right to rely upon activity that qualifies as prior art under 35 U.S.C. § 102(g)
to defend against an action by Cameron of any other party.
In view of the above, Lilly requests entry of adverse judgment against
Lilly as to all claims which correspond to the count.
(Paper No. 17, p. 2, bold emphasis added).
Regardless of Lilly's characterization of their request for adverse judgment, Lilly is
subject to the provisions of 37 C.F.R. § 1.658(c). Specifically, section 658(c) provides that:
A judgment in an interference settles all issues which (1) were raised and decided
in the interference, (2) could have been properly raised and decided in the
interference by a motion under § 1.633 (a) through (d) and (f) through (j) or
§1.634, and (3) could have been properly raised and decided in an additional
interference with a motion under § 1.633(e). A losing party who could have
properly moved, but failed to move, under § 1.633 or 1.634, shall be estopped to
take ex parte or inter partes action in the Patent and Trademark Office after the
interference which is inconsistent with that party's failure to properly move,
except that a losing party shall not be estopped with respect to any claims which
correspond, or properly could have corresponded, to a count as to which that party
was awarded a favorable judgment.
37 C.F.R. § 1.658(c)(emphasis added). Additionally, Lilly is reminded of their obligation under
37 C.F.R. § 1.56 to disclose information, including this judgment, that is material to the
patentability with respect to pending claims in other applications under consideration before the
United States Patent & Trademark Office.
Lilly's bolded statements have been accorded no weight and have no bearing upon our
decision to enter final judgment. Lilly's reasons for voluntarily requesting adverse judgment are
irrelevant to the entry of adverse judgment. Entry of an adverse judgment in an interference is a
final judgment on the merits. Judgment is entered without reservation.
Interference No. 104,104
Page No. 3
Should a party believe that we have "misapprehended" Lilly's request for adverse
judgment, that party may file a request for reconsideration under 37 C.F.R. § 1.658(b).
It is:
ORDERED that judgment on priority to Count 1 (Notice Declaring Interference, Paper
No. 1, page 5), the sole count in the interference, is awarded against Junior Party Lilly.
FURTHER ORDERED that Junior Party Lilly is not entitled to a patent containing
claims 1-13 of Lilly's U.S. Patent No. 5,688,796.
FURTHER ORDERED that a copy of this final decision shall be placed and given a
paper number in the file of Cameron, U.S. Application No. 08/628,605 and Lilly's U.S. Patent
No. 5,688,796.
FRED E. McKELVEY 	)
Senior Administrative Patent Judge 	)
) 	BOARD OF PATENT
JAMESON LEE 	) 	APPEALS
Administrative Patent Judge 	) 	AND
) 	INTERFERENCES
MICHAEL P. TIERNEY 	)
Administrative Patent Judge 	)

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.